Overview

The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)

Status:
Withdrawn

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

Both Cosopt® and Xalatan® plus Timoptic® will significantly lower IOP, however only Cosopt® will demonstrate positive hemodynamic effects. The clinical significance of this will be investigated by examining the ophthalmic and short posterior ciliary arteries to determine the blood supply to the optic nerve head, the site of damage in glaucoma

Phase:

N/A

Details

Lead Sponsor:

Meir Medical Center

Treatments:

Dorzolamide
Latanoprost
Maleic acid
Timolol